Award recordCONTRACT

REGIMED MEDICAL

PIID VA25515P0231· VHA· NATIONAL CMOP OFFICE (NCO)· 6505 · DRUGS AND BIOLOGICALS· FY2015· $30,192 net obligations· UEI M2AHN6XHZFZ5· MO

Description

CANCEL LINE ITEMS 10 AND 16

Base award description: AMIRIPTYLLINE 25/PERPHENZAINE 2MG TAB HYPROMELLOSE 0.5% OPH SOLN HCTZ 12.5MG/LOSARTAN 50MG TAB RIZATRIPTAN BENZOATE 10MG TAB PKG 18 THYROID 15MG (1/4 GRAIN) TAB

First action · last action
2014-10-17 · 2014-11-18
Transactions
3
First transaction's obligation
$49,633
Base + all options value (sum of deltas)
$30,192
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
11
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$53,624$0Base award · 2014-10-17 · this action $49,633 · running total $49,633Modification P00001 · 2014-11-18 · this action $3,991 · running total $53,624Modification P00002 · 2014-11-18 · this action -$23,432 · running total $30,192
  • Base2014-10-17+$49,633= $49,633
  • Mod P000012014-11-18+$3,991= $53,624
  • Mod P000022014-11-18-$23,432= $30,192
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-10-17+$49,633$49,633AMIRIPTYLLINE 25/PERPHENZAINE 2MG TAB HYPROMELLOSE 0.5% OPH SOLN HCTZ 12.5MG/LOSARTAN 50MG TAB RIZATRIPTAN BEN…
Mod P00001· CHANGE ORDER2014-11-18+$3,991$53,624AMIRIPTYLLINE 25/PERPHENZAINE 2MG TAB) CHANGE IN PRICE INCREASE BY $47.51 PER BOTTLE
Mod P00002· CHANGE ORDER2014-11-18−$23,432$30,192CANCEL LINE ITEMS 10 AND 16

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI M2AHN6XHZFZ5)

AwardOffice · PSC / listingNet obligationsFY
36C77026P0123NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$48,147FY2026
36C77026P0093NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$292,931FY2026
36C77026P0085NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$14,026FY2026
36C77026P0083NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$139,996FY2026
36C77026P0059NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C77025P0081NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$13,521FY2025

Other recipients under 6505 from NATIONAL CMOP OFFICE (NCO) (most recent first)

AwardRecipientOfficeNet obligationsFY
VA77016P0844ROCHE DIABETES CARE INCNATIONAL CMOP OFFICE (NCO)$494,384FY2016
VA77016P0843D & H WHOLESALE MEDICAL, INC.NATIONAL CMOP OFFICE (NCO)$30,360FY2016
VA77016P0828WESTMINSTER PHARMACEUTICALS, LLCNATIONAL CMOP OFFICE (NCO)$24,615FY2016
VA77016E0865SOUND PACKAGING LLCNATIONAL CMOP OFFICE (NCO)$11,462FY2016
VA77016E08623M COMPANYNATIONAL CMOP OFFICE (NCO)$9,177FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25515P0231_3600_-NONE-_-NONE- · retrieved 2026-09-26.